Both in Pharmaceuticals
Ardelyx vs Corvus Pharmaceuticals
Over the past year ARDX returned −38.8% and CRVS returned +24.4%; their daily moves had a correlation of 0.33.
ARDX −38.8% CRVS +24.4%Growth of $1, one year, split-adjusted
| Metric | ARDX | CRVS |
|---|---|---|
| Price | $3.09 | $9.52 |
| Market cap | $797.8M | $800.8M |
| Today | −5.50% | −3.35% |
| 1 month | −8.6% | −24.1% |
| 6 months | −52.1% | −43.1% |
| Year to date | −47.0% | +23.6% |
| 1 year | −39.8% | +23.8% |
| Revenue growth (YoY) | +23.8% | — |
| Gross margin | 95.2% | — |
| Net margin | −13.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.8× | — |
| Net cash | $30.0M | $215.2M |
| Dividend yield | — | — |
| Volatility (60d) | 49.7% | 50.1% |
| Short % of float | 11.4% | 25.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).